The author states that 'In contemporary medical culture, self-reports of pain are above question, and the treatment of pain is held up as the holy grail of compassionate medical care.' Not all opioid prescribing is for chronic pain. An Australian analysis of 4666 GP encounters found that 3.5% of opioids were prescribed for malignant neoplasm, 43.9% for chronic pain, and the remainder for non-chronic pain and other causes. 5, 9 Nevertheless, there has been increasing concern surrounding the volume of opioids used for chronic non-malignant pain and associated harms. The need for vigilance has been highlighted. 3, 9 Illicit diversion of opioids, which mirrors the increase in their prescription, is also of concern.
Introduction
In June 2014, a New South Wales deputy state coroner handed down findings into the deaths of three young patients in Sydney. 1 The coroner found that prescription drugs, some of which were opioids, caused or contributed to these unintentional deaths. The inquest highlighted examples of the difficulties in dealing with doctor-shopping behaviour, and involved hearing evidence from numerous practitioners who were often concurrently involved in the care of these patients.
More recently in December 2014, a Victorian coroner delivered findings into the death of a 38-year-old man with a long history of mental illness. 2 The man died of pneumonia in the setting of methadone and benzodiazepine use. The coroner found that the deceased received care and prescriptions from two GPs who had never met or spoken to each other about him. This reveals the difficulties and challenges of sharing prescribing information between doctors and practices. 2 In their published findings, both of these coroners, along with others around the country, have recommended reforms to the way opioids are regulated, monitored and prescribed.
Opioid use in Australia
The use of opioids in acute pain and malignant disease is rarely in dispute. In contrast, their use for chronic non-malignant pain is controversial and there is limited evidence to justify the long-term use of opioids for this indication. This is partly due to the difficulty of conducting trials in patients with such heterogeneous conditions. 3, 4 The evidence is often based on highly selected patients with minimal comorbidities, and
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Full text free online at www.australianprescriber.com VOLUME 38 : NUMBER 6 : DECEMBER 2015 back to work, or do not help. 11 The study found that approximately two-thirds of patients treated with opioids are unemployed or receiving government benefits. This has prompted calls for practitioners to re-examine the goals of opioid therapy in patients.
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Harm from opioids
Adverse events associated with opioid use have been well documented. 3, 12 Hospitalisations and deaths in which opioids have been a contributing factor are increasing. 6 As highlighted by the Coroners Court of Victoria, 82.8% of drug-related deaths in Victoria were due to prescription drugs. 13 The top contributing medicines were opioids and benzodiazepines.
The importance of regulation
The regulation of opioids is a public health issue. 14 16 All of the doctors had conditions placed on their practice, and some were suspended or de-registered. Sanctions ranged from a caution through to a reprimand.
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Responsible and lawful prescribing
Treating patients with chronic non-malignant pain is always challenging. In addition to medicolegal considerations, all prescribers should consider and balance what is in the best interests of their patient (see Fig.) . Opioids, which may have a role to play in some patients' management, should be prescribed in accordance with established guidelines and good clinical practice. In order to prescribe opioids safely, effectively, responsibly and lawfully, we recommend that GPs address a number of sequential questions.
Are opioids an appropriate choice?
To address this question, it is necessary to consider patient-specific factors that contribute to a doctor's clinical decision making including: 3, 12, 17, 18 • Should opioids be prescribed at all?
• Have all non-pharmacological options of management been considered?
• Is there a plan of management in place?
• Have the goals of treatment been defined?
• Have all of the pyschosocial factors been considered?
• Is the patient at risk of dependence?
• Are there potential drug interactions?
• Have the maximum dose and exit strategy been defined?
Before and after commencing an initial trial period of opioids, a comprehensive assessment should be performed. 19 
Are the clinical indication, dose, frequency, repeats and management plan clearly documented?
Clear, complete and adequate medical records are good clinical practice and reduce medicolegal risk.
In some states, such as NSW, they are a statutory requirement. 20 Medical records are also a requirement of the Medical Board of Australia's Code of Conduct.
21
Is an authority from the state-based pharmaceutical services unit required in addition to any PBS authority?
Many prescribers are not aware that an authority from the Pharmaceutical Benefits Scheme (PBS) is not the same as seeking an authority, or a permit, from the state-based pharmaceutical services unit or equivalent.
A sound understanding of the legislative definition of drug dependence is crucial. A prescriber must use clinical judgment to determine whether the patient is drug dependent in accordance with the legislative definition. The definition varies between states (see Table) , but usually relates to the patient's behaviour (drug seeking or otherwise) rather than the medical definition of drug dependence which traditionally refers to physical dependence.
14 In many patients, this is not a simple task. Various coroners have noted that prescribers are often limited in their ability to identify such behaviour by systemic issues such as the absence of real-time prescription monitoring.
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Opioid prescribing pitfalls
It is crucial that all prescribers are aware of and comply with the legislative requirements (see Table) . Although these differ from state to state, GPs should be aware of the following:
• If a GP knows (or ought to know) that a patient is drug dependent, an authority or permit must be sought (Table) . This applies equally in circumstances where a patient who is on opioids starts to exhibit behaviour that would reasonably lead the GP to conclude that the patient is drug dependent. Furthermore, special consideration needs to be given to patients who are (or have been) on opioid treatment programs, as some states consider these patients as drug dependent.
• If the patient is not drug dependent, in most states (except NSW) the prescriber must notify or apply for a permit or authority if the patient has been treated with opioids (by any doctor) for longer than two months (see Table) .
• In NSW, all injectable opioids, and some oral opioids (such as buprenorphine, methadone and hydromorphone), require an authority to be prescribed for longer than two months. The other opioids do not require an authority.
• In some states (such as Qld), rules for notification or permits apply for some Schedule 4 drugs of dependence, such as benzodiazepines. All states and territories -seek authority or permit before prescribing (see Table) Prescribe and document a clinically appropriate drug and dose ACT / Qld / SA / Tas. / Vic. / WA Authority required if prescribing for longer than 2 months -some special circumstances apply (see Table) Has the patient been prescribed, or are they likely to be prescribed, opioids for 2 months or more?
Seek advice from specialists, experienced colleagues, Department of Health or medical indemnity insurer NSW Authority required for certain drugs (see Table) NT Notification required in certain circumstances (see Table) Failure to apply for a permit or authority is the most common allegation brought against GPs who find themselves the subject of disciplinary proceedings.
Interstate prescriptions
The movement of patients (and GPs) across state borders is not uncommon. It is therefore important to be aware of legislative restrictions that apply in the state where the prescription is dispensed (see Table  next page). Generally, the prescribing doctor must act in accordance with the regulations that apply in that state. These regulations differ in each state, and are not the same as the regulations of the PBS. This is a particular issue for doctors working in towns close to state borders. To avoid any potential conflict with state regulations, doctors should advise the patient that prescriptions should be dispensed in the state in which the prescription is written.
Conclusion
Due to the consistent and substantial increase in opioid prescription and associated harm to patients, the regulation of Schedule 8 drugs is of increasing relevance and importance.
The gaps in knowledge and awareness of state legislation and regulation of opioids result in medicolegal risk. Furthermore, inconsistencies across states relating to the definition of drug dependency, authorities required for prescribing, and the rules of interstate prescribing, create additional complexity for practitioners. Awareness of such intricacies is essential to reduce medicolegal risk and helps ensure the safe and effective prescription of opioids to patients.
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Psychic is used to legally define a drug-addicted patient in the WA Regulations.
